Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Corticosteroid Use in Meningitis

Introduction to Corticosteroid Use

  • The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommends considering the suspension of dexamethasone if pathogens other than S. pneumoniae or H. influenzae are identified, based on observational data showing adverse outcomes in neurolisteriosis 1, 2, 3
  • A French national cohort study with 252 patients with neurolisteriosis demonstrated that treatment with dexamethasone within the first 24 hours was associated with increased mortality 1, 3

Meningitis due to Listeria monocytogenes

  • The current clinical guidelines (ESCMID 2016-2017) maintain the recommendation to suspend dexamethasone when Listeria is identified 5, 6, 4, 7
  • Patients over 50 years old and immunocompromised should receive empirical coverage with ampicillin/amoxicillin from the start, in addition to third-generation cephalosporin 1, 2, 3

Meningitis due to Cryptococcus

  • The Infectious Diseases Society of America (IDSA) 2010 guideline for cryptococcal disease does not recommend corticosteroids as standard therapy 8
  • Corticosteroids may be considered in specific situations such as multiple cryptococcomas, severe refractory intracranial hypertension, immune reconstitution inflammatory syndrome (IRIS), or complications like papillitis or papilledema with visual loss 8

Decision Algorithm for Corticosteroid Use

  • When initiating empirical treatment for bacterial meningitis, dexamethasone 10 mg every 6 hours should be started with or before the first antibiotic in all adults with suspected bacterial meningitis 5, 6, 4
  • Once the pathogen is identified, dexamethasone should be continued for 4 days if the pathogen is S. pneumoniae or H. influenzae, and suspended if the pathogen is L. monocytogenes 1, 3, 5, 6, 4